The Data Behind the Decisions.
DxRx AI's performance is validated through independent clinical trials, real-world outcome studies, and continuous specialist benchmarking. Every claim is backed by peer-reviewed evidence.
Request Evidence PackageIndependently validated. Peer-reviewed. Reproducible.
Multicenter Randomized Controlled Trial
4,847 patients across 8 academic medical centers
DxRx AI reduced time-to-correct-diagnosis by 61% compared to standard clinical workup, with no increase in false-positive rate.
Real-World Evidence Study
22,000+ patients across 12 community and academic health systems
Health systems using DxRx AI saw a 38% reduction in contraindication-related adverse events and a 2.3x improvement in time-to-treatment across all acuity levels.
Systematic Review & Meta-Analysis
Pooled analysis of 9 independent validation studies, n=67,000+
Across all disease categories and care settings, DxRx AI demonstrated superior diagnostic performance to unaided clinical judgment, with the largest effect sizes in sepsis, ACS, and stroke.
94%+ accuracy across 47 disease categories.
Performance validated against specialist consensus diagnosis. Categories represent the highest-volume and highest-acuity presentations in acute care settings.
Accuracy measured as agreement with specialist consensus diagnosis (≥2 board-certified specialists per case). Validation cohort: 8,200 prospectively collected cases, held out from training data. Reported as top-1 diagnostic accuracy.
Better decisions. Measurable outcomes.
Time-to-correct-diagnosis
Multicenter RCT, n=4,847
Contraindication-related adverse events
Real-world evidence, n=22,000+
30-day readmission rate
Real-world evidence, 12 health systems
Average cost per episode of care
Health economics analysis, 2025
Cleared, certified, and continuously monitored.
FDA 510(k) Cleared
Class II medical device clearance for clinical decision support. K241892.
CE Mark (EU MDR)
Conformity assessment under EU Medical Device Regulation 2017/745.
MHRA Registered (UK)
Registered as a medical device with the UK Medicines and Healthcare products Regulatory Agency.
TGA Listed (Australia)
Listed on the Australian Register of Therapeutic Goods.
Request the Full Evidence Dossier.
Download peer-reviewed publications, validation datasets, and health economics analyses.